ArticleJournal of market access & health policy2023

Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting.

Niamh Carey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.